{"id":1652,"date":"2018-09-07T16:30:05","date_gmt":"2018-09-07T15:30:05","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=1652"},"modified":"2018-09-07T10:15:15","modified_gmt":"2018-09-07T09:15:15","slug":"latanoprost-timolol-eye-drops-recall","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","title":{"rendered":"Latanoprost Timolol eye drops recall"},"content":{"rendered":"<p>A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA).<\/p>\n<p>The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an \u2018out of specification result for an unknown impurity\u2019 that was identified during testing. Medical professionals are to stop providing the eye drops to patients, and suppliers and distributors are to cease moving the eye drops as well.<\/p>\n<p>The NHS has been pushing the news throughout the Service to ensure batches affected by the Latanoprost Timolol eye drops recall are not used.<\/p>\n<p><!--more--><\/p>\n<h3><strong>Batch affected by the Latanoprost Timolol eye drops recall<\/strong><\/h3>\n<p>The information for the batch affected by the Latanoprost Timolol eye drops recall is as follows:<\/p>\n<p>Batch Number: 087B087 (pack size 1 x 2.5 mL)<\/p>\n<p>First Distrusted: 15<sup>th<\/sup> June 2017<\/p>\n<p>Expiry Date: January 2019<\/p>\n<p>You can read the <a href=\"https:\/\/assets.publishing.service.gov.uk\/media\/5ae9d0b640f0b63154caad73\/EL_18_A_08.pdf\" target=\"_blank\" rel=\"noopener\"><strong>advice letter issued here.<\/strong><\/a><\/p>\n<h3><strong>Latanoprost Timolol eye drops recall announcement<\/strong><\/h3>\n<p>The Latanoprost Timolol eye drops recall has been announced as a Class 3 Medicines Recall by the MHRA. Stocks of the eye drops are to be quarantined and returned for replacements to be issued.<\/p>\n<p>A worrying factor may be that the batch affected by the recall appears to have been first disrupted almost a year before the recall was announced. If the recalled batch may put a user at risk if they use the eye drops, we could be looking at a bigger problem if anyone suffers any adverse effects.<\/p>\n<p>No issues have been reported so far, but although the recalls are intended to make sure that supplies are stopped, and affected batches are quarantined in such recalls, it\u2019s not always so easy to get the message out to the actual people who use the products. We know about the Latanoprost Timolol eye drops recall because we monitor such things as a firm of <a href=\"https:\/\/www.groupactionlawyers.co.uk\/about-us\" target=\"_blank\" rel=\"noopener\"><strong>Group Action lawyers who often engage in medical product litigation<\/strong><\/a>, but users are at risk when they have no idea that there\u2019s a problem.<\/p>\n<p>This is always a worrying aspect of any medical product or drugs recall.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA). The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an \u2018out of specification result for an unknown impurity\u2019 that was identified during testing. Medical professionals are to stop &hellip; <a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Latanoprost Timolol eye drops recall<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":475,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[5,27,10],"tags":[60,61,20,8],"class_list":["post-1652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","category-products","category-recalls","tag-medical-product","tag-medical-recall","tag-mhra","tag-recalls"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Latanoprost Timolol eye drops recall - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA) and FDC Pharma.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Latanoprost Timolol eye drops recall - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA) and FDC Pharma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-07T15:30:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"725\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Latanoprost Timolol eye drops recall\",\"datePublished\":\"2018-09-07T15:30:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall\"},\"wordCount\":348,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/hoya-optics-recall.png?fit=725%2C250&ssl=1\",\"keywords\":[\"medical product\",\"medical recall\",\"mhra\",\"recalls\"],\"articleSection\":[\"Medical\",\"Products\",\"Recalls\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall\",\"name\":\"Latanoprost Timolol eye drops recall - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/hoya-optics-recall.png?fit=725%2C250&ssl=1\",\"datePublished\":\"2018-09-07T15:30:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA) and FDC Pharma.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/hoya-optics-recall.png?fit=725%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/hoya-optics-recall.png?fit=725%2C250&ssl=1\",\"width\":725,\"height\":250,\"caption\":\"eye claims\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/latanoprost-timolol-eye-drops-recall#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Latanoprost Timolol eye drops recall\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles &amp; Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Latanoprost Timolol eye drops recall - Group Action Lawyers","description":"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA) and FDC Pharma.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","og_locale":"en_GB","og_type":"article","og_title":"Latanoprost Timolol eye drops recall - Group Action Lawyers","og_description":"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA) and FDC Pharma.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","og_site_name":"Group Action Lawyers","article_published_time":"2018-09-07T15:30:05+00:00","og_image":[{"width":725,"height":250,"url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1","type":"image\/png"}],"author":"Author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Latanoprost Timolol eye drops recall","datePublished":"2018-09-07T15:30:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall"},"wordCount":348,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1","keywords":["medical product","medical recall","mhra","recalls"],"articleSection":["Medical","Products","Recalls"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall","name":"Latanoprost Timolol eye drops recall - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1","datePublished":"2018-09-07T15:30:05+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA) and FDC Pharma.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1","width":725,"height":250,"caption":"eye claims"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/latanoprost-timolol-eye-drops-recall#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Latanoprost Timolol eye drops recall"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles &amp; Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/01\/hoya-optics-recall.png?fit=725%2C250&ssl=1","jetpack-related-posts":[{"id":770,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sodium-cromoglicate-eye-drops-mhra-class-2-medicines-recall","url_meta":{"origin":1652,"position":0},"title":"MHRA publishes a class 2 Medicines recall for Sodium Cromoglicate eye drops","author":"Admin","date":"28th June 2017","format":false,"excerpt":"The Medicines and Health products Regulation Agency (MHRA) published a medical drug alert on the 18th May 2017 issuing a precautionary recall for bottles of eye drops amidst concerns that the solution can solidify in its container. Sodium Cromoglicate solution eye drops are typically used to treat red, watery and\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"eye compensation","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2232,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/eye-injury-group-action-claims-for-compensation","url_meta":{"origin":1652,"position":1},"title":"Eye injury group action claims for compensation","author":"Author","date":"18th January 2022","format":false,"excerpt":"Eye injury group action cases can mean representing some of the most seriously injured people there can be when this vital sense is harmed or adversely affected by a problem. We have, and still do, represent people claiming in group\/multi-party cases for eye injury claims. If you need advice about\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"eye compensation","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2698,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/in-the-news-carbomer-eye-gels-mhra-recall","url_meta":{"origin":1652,"position":2},"title":"In The News: Carbomer Eye Gels MHRA Recall","author":"Author","date":"23rd January 2024","format":false,"excerpt":"In recent publications, the MHRA has publicised a recall for specific brands of Carbomer Eye Gels due to a potential risk of infection. At The Group Action Lawyers, we understand the concerns and challenges faced by those who could be affected. This article aims to shed light on some of\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"carbomer eye gels","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-Lawyer-Professional-Person-Meeting-45-Copy-min.jpg?fit=695%2C509&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":234,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/teva-uk-ltd-has-recalled-progestogen-only-pill-drug","url_meta":{"origin":1652,"position":3},"title":"&#8220;Progestogen-only Pill Drug Recalls&#8221; &#8211; Teva UK Ltd has recalled drugs due to impurities showing in their routine testing","author":"Author","date":"17th November 2016","format":false,"excerpt":"Teva UK Limited are one of the latest pharmaceutical manufacturers that have recalled a batch of their drugs. The Nacrez 75 mg film-coated tablets have been recalled due to impurities found as part of their routine testing. The recall is said to be a precautionary measure taken by the company\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2795,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/legency-remedies-eye-wash-recall","url_meta":{"origin":1652,"position":4},"title":"Legency Remedies Eye Wash Recall","author":"Author","date":"4th June 2024","format":false,"excerpt":"The safety of medical products is paramount, especially when they are meant to address critical health needs. We look at the Legency Remedies eye wash recall. When products like eye wash solutions are recalled due to safety concerns, individuals who have used them may face unforeseen health risks. If you\u2026","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/health"},"img":{"alt_text":"Legency Remedies eye wash recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-SEOSDB-Desk-Computer-Typing-13-Copy-min.png?fit=915%2C610&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-SEOSDB-Desk-Computer-Typing-13-Copy-min.png?fit=915%2C610&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-SEOSDB-Desk-Computer-Typing-13-Copy-min.png?fit=915%2C610&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/ALSO-CEL-DBL-SEOSDB-Desk-Computer-Typing-13-Copy-min.png?fit=915%2C610&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1694,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/were-you-affected-by-the-cough-syrup-mould-recall","url_meta":{"origin":1652,"position":5},"title":"Were you affected by the cough syrup mould recall?","author":"Author","date":"30th November 2018","format":false,"excerpt":"Were you affected by the cough syrup mould issues that came to light over summer? In the midst of the season for colds and coughs, you may want to take heed of this warning if you\u2019re not aware of it already. Over summer, a formal recall was issued with the\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"defective product claims","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/09\/kids_toys_merger.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/09\/kids_toys_merger.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/09\/kids_toys_merger.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/09\/kids_toys_merger.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=1652"}],"version-history":[{"count":1,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1652\/revisions"}],"predecessor-version":[{"id":1653,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1652\/revisions\/1653"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/475"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=1652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=1652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=1652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}